| Robert C Friess, DO | |
|
5901 Monclova Rd, Maumee, OH 43537-1855 | |
| (419) 897-8370 | |
| Not Available |
| Full Name | Robert C Friess |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 33 Years |
| Location | 5901 Monclova Rd, Maumee, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740253921 | NPI | - | NPPES |
| 0170425 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 34.005552 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Promedica Toledo Hospital | Toledo, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Promedica Central Physicians | 2365348190 | 818 |
News Archive
Republicans said Tuesday that they might allow $250 billion to $300 billion of additional tax revenue as part of a deal to shave $1.2 trillion from federal deficits over the next 10 years. Democrats, though, did not seem to view the plan as a major concession.
New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies.
Merck Canada Inc. announced today that KEYTRUDATM (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. KEYTRUDA is a humanized monoclonal antibody that works by increasing the ability of the body's immune system to fight advanced melanoma, the most serious form of skin cancer. It is the first of a new class of therapies called anti-PD-1s approved in Canada.
A pelvic MRI scan with IV contrast and rectal balloon is highly effective in identifying local recurrence even at low PSA values in prostate cancer patients with a rising or persistently elevated PSA after prostatectomy, according to a study presented April 29, 2011, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. The symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).
› Verified 1 days ago
| Entity Name | Promedica Central Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043270150 PECOS PAC ID: 2365348190 Enrollment ID: O20031211000226 |
News Archive
Republicans said Tuesday that they might allow $250 billion to $300 billion of additional tax revenue as part of a deal to shave $1.2 trillion from federal deficits over the next 10 years. Democrats, though, did not seem to view the plan as a major concession.
New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies.
Merck Canada Inc. announced today that KEYTRUDATM (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. KEYTRUDA is a humanized monoclonal antibody that works by increasing the ability of the body's immune system to fight advanced melanoma, the most serious form of skin cancer. It is the first of a new class of therapies called anti-PD-1s approved in Canada.
A pelvic MRI scan with IV contrast and rectal balloon is highly effective in identifying local recurrence even at low PSA values in prostate cancer patients with a rising or persistently elevated PSA after prostatectomy, according to a study presented April 29, 2011, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. The symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).
› Verified 1 days ago
| Entity Name | Southwest Anesthesia Services Psc, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188129 PECOS PAC ID: 3779483631 Enrollment ID: O20040109000000 |
News Archive
Republicans said Tuesday that they might allow $250 billion to $300 billion of additional tax revenue as part of a deal to shave $1.2 trillion from federal deficits over the next 10 years. Democrats, though, did not seem to view the plan as a major concession.
New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies.
Merck Canada Inc. announced today that KEYTRUDATM (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. KEYTRUDA is a humanized monoclonal antibody that works by increasing the ability of the body's immune system to fight advanced melanoma, the most serious form of skin cancer. It is the first of a new class of therapies called anti-PD-1s approved in Canada.
A pelvic MRI scan with IV contrast and rectal balloon is highly effective in identifying local recurrence even at low PSA values in prostate cancer patients with a rising or persistently elevated PSA after prostatectomy, according to a study presented April 29, 2011, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. The symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert C Friess, DO 584 Fox View Ct, Perrysburg, OH 43551-1885 Ph: (419) 479-1274 | Robert C Friess, DO 5901 Monclova Rd, Maumee, OH 43537-1855 Ph: (419) 897-8370 |
News Archive
Republicans said Tuesday that they might allow $250 billion to $300 billion of additional tax revenue as part of a deal to shave $1.2 trillion from federal deficits over the next 10 years. Democrats, though, did not seem to view the plan as a major concession.
New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies.
Merck Canada Inc. announced today that KEYTRUDATM (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. KEYTRUDA is a humanized monoclonal antibody that works by increasing the ability of the body's immune system to fight advanced melanoma, the most serious form of skin cancer. It is the first of a new class of therapies called anti-PD-1s approved in Canada.
A pelvic MRI scan with IV contrast and rectal balloon is highly effective in identifying local recurrence even at low PSA values in prostate cancer patients with a rising or persistently elevated PSA after prostatectomy, according to a study presented April 29, 2011, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. The symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).
› Verified 1 days ago
Thomas W Gerken, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5901 Monclova Rd, Maumee, OH 43537 Phone: 419-897-8370 | |
John L. Rust Jr., MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5901 Monclova Rd, Maumee, OH 43537 Phone: 419-897-8370 | |
Patrick J. Schafer, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5901 Monclova Rd, Maumee, OH 43537 Phone: 419-897-8370 | |
Thomas J. Andersen, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 5901 Monclova Rd, Maumee, OH 43537 Phone: 419-897-8370 | |
Samuel Agubosim, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1574 Henthorne Dr, Suite C, Maumee, OH 43537 Phone: 419-794-1170 Fax: 419-794-1171 | |
Bashar N Jouma, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5901 Monclova Rd, Heart Center, Maumee, OH 43537 Phone: 419-893-5911 | |
Elizabeth Fowler, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5901 Monclova Rd, Maumee, OH 43537 Phone: 419-897-8370 |